Today, the Federal Trade Commission (FTC) and the Department of Justice (DOJ) convened its third and final listening session on ways to make prescription drugs more affordable for Americans by promoting competition. This session focused on turning insights from the previous two sessions into action and featured Congressional staffers who spoke to various legislative efforts to curb anticompetitive practices in… (Slifer, August 4, 2025) #Drug Pricing, #Food and Drug Administration, #Generic Drugs, #Pharmacy Benefit Managers, #Prescription Drugs